Testing effectiveness (Phase 2)Ended earlyNCT00455429
What this trial is testing
An Efficacy and Safety Study of JNJ-26113100 in the Treatment of Adult Atopic Dermatitis
Who this might be right for
Atopic Dermatitis
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 84